These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23511419)

  • 21. Discovery of novel 17-phenylethylaminegeldanamycin derivatives as potent Hsp90 inhibitors.
    Li Z; Jia L; Wang J; Wu X; Shi G; Lu C; Shen Y
    Chem Biol Drug Des; 2015 Feb; 85(2):181-8. PubMed ID: 24903735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Total synthesis of herbimycin A.
    Canova S; Bellosta V; Bigot A; Mailliet P; Mignani S; Cossy J
    Org Lett; 2007 Jan; 9(1):145-8. PubMed ID: 17192106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis, and biological evaluation of conformationally constrained cis-amide Hsp90 inhibitors.
    Duerfeldt AS; Brandt GE; Blagg BS
    Org Lett; 2009 Jun; 11(11):2353-6. PubMed ID: 19435295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heat shock protein 90: inhibitors in clinical trials.
    Biamonte MA; Van de Water R; Arndt JW; Scannevin RH; Perret D; Lee WC
    J Med Chem; 2010 Jan; 53(1):3-17. PubMed ID: 20055425
    [No Abstract]   [Full Text] [Related]  

  • 25. Discovery of diamine-linked 17-aroylamido-17-demethoxygeldanamycins as potent Hsp90 inhibitors.
    Li Z; Jia L; Wang J; Wu X; Hao H; Wu Y; Xu H; Wang Z; Shi G; Lu C; Shen Y
    Eur J Med Chem; 2014 Nov; 87():346-63. PubMed ID: 25277067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benzoquinone ansamycin heat shock protein 90 inhibitors modulate multiple functions required for tumor angiogenesis.
    Sanderson S; Valenti M; Gowan S; Patterson L; Ahmad Z; Workman P; Eccles SA
    Mol Cancer Ther; 2006 Mar; 5(3):522-32. PubMed ID: 16546966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New non-quinone geldanamycin analogs from genetically engineered Streptomyces hygroscopicus.
    Wu CZ; Moon AN; Jang JH; Lee D; Kang SY; Park JT; Ahn JS; Hwang BY; Kim YH; Lee HS; Hong YS
    J Antibiot (Tokyo); 2011 Jun; 64(6):461-3. PubMed ID: 21448187
    [No Abstract]   [Full Text] [Related]  

  • 28. Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin.
    Roe SM; Prodromou C; O'Brien R; Ladbury JE; Piper PW; Pearl LH
    J Med Chem; 1999 Jan; 42(2):260-6. PubMed ID: 9925731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New, non-quinone fluorogeldanamycin derivatives strongly inhibit Hsp90.
    Hermane J; Bułyszko I; Eichner S; Sasse F; Collisi W; Poso A; Schax E; Walter JG; Scheper T; Kock K; Herrmann C; Aliuos P; Reuter G; Zeilinger C; Kirschning A
    Chembiochem; 2015 Jan; 16(2):302-11. PubMed ID: 25572106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Geldanamycin, radicicol, and chimeric inhibitors of the Hsp90 N-terminal ATP binding site.
    Hadden MK; Lubbers DJ; Blagg BS
    Curr Top Med Chem; 2006; 6(11):1173-82. PubMed ID: 16842154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rational design and synthesis of ansa-adenosines as potential antitumor agents.
    Muranaka K; Ichikawa S; Matsuda A
    Nucleic Acids Symp Ser (Oxf); 2009; (53):5-6. PubMed ID: 19749232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-mediated targeted disruption of multiple protein activities through functional inhibition of the Hsp90 chaperone complex.
    Stravopodis DJ; Margaritis LH; Voutsinas GE
    Curr Med Chem; 2007; 14(29):3122-38. PubMed ID: 18220746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and evaluation of radamide analogues, a chimera of radicicol and geldanamycin.
    Hadden MK; Blagg BS
    J Org Chem; 2009 Jul; 74(13):4697-704. PubMed ID: 19492825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo Evaluation of 17-phenylpropylamine/phenoxyethylamine- 17-demethoxygeldanamycins as Potent Hsp90 Inhibitors.
    Li Z; Jia L; Xu H; Lu C; Shena Y
    Med Chem; 2015; 11(5):482-8. PubMed ID: 25537129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histone deacetylase activity mediates acquired resistance towards structurally diverse HSP90 inhibitors.
    Chai RC; Vieusseux JL; Lang BJ; Nguyen CH; Kouspou MM; Britt KL; Price JT
    Mol Oncol; 2017 May; 11(5):567-583. PubMed ID: 28306192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biosynthesis of the heat-shock protein 90 inhibitor geldanamycin: new insight into the formation of the benzoquinone moiety.
    Lee D; Lee K; Cai XF; Dat NT; Boovanahalli SK; Lee M; Shin JC; Kim W; Jeong JK; Lee JS; Lee CH; Lee JH; Hong YS; Lee JJ
    Chembiochem; 2006 Feb; 7(2):246-8. PubMed ID: 16381049
    [No Abstract]   [Full Text] [Related]  

  • 37. Molecular characterization of macbecin as an Hsp90 inhibitor.
    Martin CJ; Gaisser S; Challis IR; Carletti I; Wilkinson B; Gregory M; Prodromou C; Roe SM; Pearl LH; Boyd SM; Zhang MQ
    J Med Chem; 2008 May; 51(9):2853-7. PubMed ID: 18357975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Geldanamycin and its analog induce cytotoxicity in cultured human retinal pigment epithelial cells.
    Wu WC; Wu MH; Chang YC; Hsieh MC; Wu HJ; Cheng KC; Lai YH; Kao YH
    Exp Eye Res; 2010 Aug; 91(2):211-9. PubMed ID: 20493187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ZAP-70 is a novel conditional heat shock protein 90 (Hsp90) client: inhibition of Hsp90 leads to ZAP-70 degradation, apoptosis, and impaired signaling in chronic lymphocytic leukemia.
    Castro JE; Prada CE; Loria O; Kamal A; Chen L; Burrows FJ; Kipps TJ
    Blood; 2005 Oct; 106(7):2506-12. PubMed ID: 15972449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent.
    Stebbins CE; Russo AA; Schneider C; Rosen N; Hartl FU; Pavletich NP
    Cell; 1997 Apr; 89(2):239-50. PubMed ID: 9108479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.